Women’s healthcare has long split hormonal, metabolic, and reproductive conditions into separate specialties, even though the body treats them as one system. The medical field acknowledged that problem in May 2026, when an international consensus published in The Lancet renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS), recognizing that a condition affecting more than 170 million women reaches far beyond the ovaries. Allara answers that fragmentation with a virtual, insurance-covered practice that pairs women’s health clinicians with registered dietitians to treat hormonal, metabolic, and reproductive health in one care relationship. Allara’s own survey of more than 1,600 new members found that 58% had already spoken with two or more providers about their symptoms, and 80% of those who had seen another provider said clinicians dismissed or minimized them. More than 120,000 women have received care through Allara, and among members with irregular cycles, 69% reported improved menstrual regularity. With in-network access through major insurers in most states, Allara now plans to extend AI tools across the patient journey, from intake to ongoing treatment management, while building one of the largest datasets in women’s health.
AlleyWatch sat down with Allara Founder and CEO Rachel Blank to learn more about the business, its future plans, recent funding round, and much, much more…
Who were your investors and how much did you raise?
We raised a $30 million investment round, bringing our total funding to $75M. Existing investors Index Ventures and GV, among others, increased their commitments, alongside new investors Camino Partners, Foreground, and Family Fund.
Tell us about the product or service that Allara offers.
Allara is a virtual, insurance-covered women’s health company providing comprehensive care for hormonal and metabolic conditions. We have both women’s health clinicians and registered dietitians available to work collaboratively to deliver better patient health outcomes. Patients can receive medical care, nutrition support, manage prescriptions, get advanced lab testing, and walk away with a personalized treatment plan to support their health needs.
We’ve now served more than 120,000 women across conditions and life stages including PCOS / PMOS, thyroid disorders, fertility, postpartum, metabolic health and perimenopause. We’ve also expanded the treatment options available through Allara’s care to include access to GLP-1 medications paired with lifestyle and nutrition guidance, hormone replacement therapy, prescription skincare and hair loss treatments, as well as virtual urgent care for needs like BV, UTIs and STI testing often common with hormonal conditions.
What inspired the start of Allara?
Allara started with my own experience as a frustrated patient. I was diagnosed with PCOS, now PMOS, in my 20s. It took about three years, and more doctors, tests and opinions than I can count, to get clear answers about what was happening in my body.
That showed me how hard it is for women with chronic conditions or hormonal health concerns to get the care they deserve. Women see multiple providers, wait years for answers, and have individual symptoms treated without anyone looking at how their reproductive, hormonal and metabolic health fit together. I knew there had to be a better way to take the burden off of the patient and bring it all together.
We built Allara, where specialists collaborate from the start. Care is immediately available (same-day in most cases), is comprehensive and managed in one place, so a woman isn’t the one managing it all on her own.
PCOS / PMOS was our starting point, but we quickly saw that many women who came to us had other hormonal, metabolic or endocrine conditions, sometimes several at once. The same coordinated model worked for them too, and that became the foundation for Allara.
How is Allara different?
Allara is not a one-size-fits-all approach to care and we often are the care partner for women after they’ve tried simpler solutions or need a more hands-on approach to feeling better. At the core of our platform are clinical visits, where providers develop a comprehensive understanding of each patient and tailor treatment to her needs. Every patient is paired with a care team of medical providers and registered dietitians who evaluate how her hormonal, metabolic and reproductive health are connected, rather than treating individual symptoms in isolation.
We have also made that care significantly more accessible. Most patients can be seen the same day or within a week, rather than waiting months for a specialist. Our platform supports a broad range of needs, from PMOS and thyroid care to GLP-1 treatment, hormone replacement therapy and urgent care, so patients can address more of their health in one place. Because we are covered by insurance, patients can build an ongoing relationship with their care team without paying the hundreds of dollars a month that concierge care often costs.
What market does Allara target and how big is it?
We serve women across hormonal, metabolic and reproductive health, so the opportunity extends far beyond any single condition. Our patients include women managing PCOS/PMOS, thyroid disorders, endometriosis and metabolic health conditions, as well as women navigating fertility, postpartum and perimenopause.
1 in 3 women has a hormonal health condition, PCOS/PMOS affects roughly one in 10 women, 1 in 8 women will develop a thyroid disorder in her lifetime, and endometriosis affects about 10% of women of reproductive age, and all women will go through menopause.
What we’ve learned is that these needs frequently overlap and evolve throughout a woman’s life. That means we don’t view Allara as a point solution for one diagnosis; we’re building a platform capable of supporting women across multiple conditions and life stages.
What’s your business model?
Allara is an insurance-covered healthcare platform. We’re in-network with major insurers in most states, and we generate revenue primarily through insurance reimbursement for care visits, alongside cash-pay services, prescriptions and supplements. We’re also expanding distribution through partnerships with employers, health systems.
What makes the model compelling is the length of the patient relationship. Women often come to Allara for 2-3 symptoms and stay for others as their health evolves. That lifetime value makes our growth capital-efficient.
How are you preparing for a potential economic slowdown?
We know any out-of-pocket cost is a real barrier, especially when money is tight. That’s exactly why insurance coverage is central to our model. It’s how we make specialty care accessible to most women. For women between coverage, our self-pay option is designed to keep their care continuous, and it’s a fraction of what concierge or out-of-network specialty care typically costs. All elements of our care as HSA/ FSA eligible as well.
Another of the things that gives us confidence is that the underlying economics of the business are strong. We didn’t raise this round because we needed an enormous amount of capital to sustain growth. We raised it from a position where we could be intentional about investing in the next phase of the company.
What was the funding process like?
There’s a perception that because women’s health has become a buzzier category, raising capital has gotten dramatically easier. That hasn’t been our experience. It’s still an education process, and the conversations that move investors are grounded in data: how many women we’ve served, how long they stay with us, and the outcomes they achieve.
What made this round different was that we could point to years of proof. Index Ventures and GV, who have watched our care model evolve over time, increased their commitments, and new investors like Camino Partners, Foreground and Family Fund joined because they saw the same results. That gave us the confidence to invest in the next phase: building new features and using AI to enhance the care experience, so we can reach millions more women.
What are the biggest challenges that you faced while raising capital?
In this round we had to explain what it means to be an AI-first healthcare company with doctors at the core. Investors understandably asked whether AI would eventually replace doctors and what that would mean for Allara. We were able to articulate why we believe human doctors will remain central to complex specialty care, and how AI can make that care better.
Our patients want clinical expertise, but they also want a relationship with someone who listens, takes them seriously, and understands their history. That matters especially in women’s health, where so many patients have spent years feeling dismissed. We believe that human relationships will remain essential, even as technology advances.
At the same time, doctors are overburdened and overworked. An AMA-supported study found that physicians spent nearly twice as much time on electronic health records and desk work as they did face-to-face with patients. We use AI to reduce that administrative burden and help our providers deliver higher-quality care with less burn out. Our vision is to give doctors more time and capacity to care for patients, creating a better experience for both.
What factors about your business led your investors to write the check?
Our investors saw proof that both the care model and the business model work.
We’ve served more than 120,000 women, we have measurable clinical outcomes, and patients continue using Allara across multiple healthcare needs over time. The economics reflect that long-term relationship: we acquire patients efficiently and generate high lifetime value because women keep coming back to us as her care needs expand.
There’s also a significant opportunity ahead. We’re expanding distribution of an insurance-covered model, building AI that increases our providers’ capacity, and drawing on one of the largest datasets in women’s health to shape better care. This round allows us to accelerate all three.
What are the milestones you plan to achieve in the next six months?
Our priorities are expanding access to Allara through broader distribution and strategic partnerships, growing the range of care we provide within a single patient relationship, and accelerating our AI capabilities.
On the provider side, we’re developing technology that synthesizes patient information, supports clinical decision-making and reduces administrative burden. We’re also launching patient-facing AI in the Allara app to guide women between visits.
Research is another area we’re excited about. With a large patient population and dataset, we have an opportunity to contribute to research in women’s health conditions that have historically been underfunded and understudied, including GLP-1 care, endometriosis and longer-term pregnancy outcomes. All of it serves the same goal: bringing better care to millions more women.
What advice can you offer companies in New York that do not have a fresh injection of capital in the bank?
Focus on the fundamentals of the business rather than assuming capital is the solution to every growth problem. One thing we’ve been very disciplined about at Allara is understanding our economics: what it costs to acquire a patient, how we retain that patient and how we continue providing value to her over time. We’ve also had enormous success over the years by leaning into our organic community, especially on social media – we have nearly 300,000 followers across channels. Start with community driven organic growth, it can get you quite far.
Focus on the fundamentals of the business rather than assuming capital is the solution to every growth problem. One thing we’ve been very disciplined about at Allara is understanding our economics: what it costs to acquire a patient, how we retain that patient and how we continue providing value to her over time. We’ve also had enormous success over the years by leaning into our organic community, especially on social media – we have nearly 300,000 followers across channels. Start with community driven organic growth, it can get you quite far.
Where do you see the company going now over the near term?
Our goal is to become the first place women turn for their healthcare.
Today, many of our patients stay with us through multiple stages of their lives, and that’s the model we want to scale.
We’re aiming to transform the way women navigate and experience their health. With AI built into our care experience, women will be able to find answers, know what comes next in their care, and work with providers who understand the full picture of their health, instead of starting over every time or experiencing huge steps back in managing their health symptoms and goals. Plus we’re expanding partnerships with payers and employers to make our care as accessible as possible.
Women shouldn’t have to fight for quality healthcare. We’re building a company that makes sure they never have to.
What’s your favorite fall destination in and around the city?
I became a new mom this summer, so I’ve been especially excited for fall at the Union Square Greenmarket. The apple cider, the cozy fall feeling, and getting to bring my son for the first time make it a really special moment this year.
